Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $470.13, denoting a +2.54% move from the preceding trading day.

AbbVie's dividends add to its attractiveness at an uncertain time, adding to robust price returns over time. Click here to ...

Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

The stock market hit new highs to start the week as Wall Street celebrates the upbeat opening to second-quarter earnings ...

Diverging inflation trends see developed markets facing rising prices due to tariffs, while emerging markets experience ...

Leerink Partners is especially bullish about the company’s upcoming programs ABCL575, an OX40L antagonist targeting atopic ...

JP Morgan reported in their recent outlook piece that "The backdrop for the European consumer is also improving. Real wages ...

Rocket Lab stock is currently overvalued, and in a base case, you can expect lateral 12-month price movement. Click here to ...

"The support for the day is seen at 24,900, while the resistance is seen at 25,300. The Bank Nifty would have the daily range ...

Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...

Now, it’s worth noting Stock Advisor’s total average return is 1,055% — a market-crushing outperformance compared to 180 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...